Valproate semisodium

Drug Profile

Valproate semisodium

Alternative Names: [14C]-Sodium Valproate; Depakote; Depakote ER; Divalproex; Divalproex sodium; Divalproex sodium DR 500mg tablets - Abbott Laboratories; Epival; Epival ER; LA40220

Latest Information Update: 24 Mar 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Abbott Laboratories
  • Class Antiepileptic drugs; Antimanics; Antimigraines
  • Mechanism of Action GABA uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Bipolar disorders; Epilepsy; Migraine
  • Phase III Dementia

Most Recent Events

  • 28 Sep 2018 Sanofi plans a phase I BEX15316 trial for Epilepsy (In volunteers) in Canada and USA (PO) in November 2018 (NCT03681158) (EudraCT2017-004987-36)
  • 24 Jun 2018 Biomarkers information updated
  • 25 Apr 2017 Abbott terminated a phase III trial in Dementia (In adults, In the elderly) as the investigator closed study and left VAMC in USA (NCT00315900)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top